WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that
develops wearable medical technology and point-of-care tests to help
patients and physicians manage chronic pain, nerve diseases, and sleep
disorders, today reported that it has begun to ship Quell devices to
healthcare providers in the United States. Since the Company fielded its
direct sales force in mid-April over 100 physician practices providing
front-line care to patients with chronic pain have purchased Quell to
stock for resale to their patients. These practices include podiatrists,
chiropractors, pain specialists and others.
"Patients come to us looking for comprehensive solutions," said Dr. Hal
Ornstein, a New Jersey-based podiatrist and Chairman of the American
Academy of Podiatric Practice Management. "They expect clinicians to
have the latest technology to address their condition. More and more
providers are dispensing products like Quell out of their office as they
see how it contributes to better care."
Quell is an over-the-counter wearable pain relief device that utilizes
proprietary non-invasive neurostimulation technology to provide pain
relief. The device is designed for people with conditions such as
diabetic nerve pain, low back and leg pain, fibromyalgia, and pain
associated with osteoarthritis. The advanced wearable device is
lightweight and can be worn during the day while active, and at night
while sleeping. It has been cleared by the FDA for treatment of chronic
pain without a prescription. Users of the device have the option of
using their smart phone to track and personalize their pain therapy
through the Quell Relief app which is available in the Apple app store.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. For more information, please visit www.QuellRelief.com
and www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150528006006/en/
